ORIX (IX) Q2 FY2027: Adjusted Profit Beats, Kioxia Gain Set to Reverse

Summary
ORIX first-half FY2027 adjusted net income of ¥317.5 billion beat its forecast, while USA & Europe profit halved and a ¥190 billion Kioxia loss looms in Q3.
ORIX (IX) first-half FY2027 results, filed on Form 6-K on November 9, 2026 for April-September 2026, delivered the profit the company had forecast, but most of it came from gains that will not repeat [1]. Net income attributable to shareholders was ¥856.2 billion, up 216% year over year. Adjusted net income, which strips out Kioxia-related gains, was ¥317.5 billion, above the ¥300 billion the company forecast in August [1][2].
Four questions framed this report: adjusted profit, reinvestment after the ORIX Bank sale, new-policy profit at the life insurer, and how much the USA & Europe business depends on private equity gains. ORIX Bank was sold as planned. Insurance profit grew while insurance revenue fell. USA & Europe profit halved from the first quarter as private equity gains receded. Overall, core profit came in slightly ahead of company expectations, but the Kioxia gain is set to reverse in the third quarter, and new investment is lagging the cash ORIX has recovered from asset sales.
ORIX is a Tokyo-based financial group that runs leasing and lending, life insurance, asset management, private equity investing, aircraft and ships, energy and real estate businesses [4]. Its profit comes from recurring income such as rent, interest, premiums and management fees, plus gains from buying, operating and then selling assets.
Adjusted profit beat the forecast; Kioxia gains turn to a loss in Q3
Both reported and adjusted first-half profit met or slightly exceeded the August forecast. After Toshiba sold and remeasured its Kioxia shares, ORIX recognized equity-method income through its 20%-owned TB Investment with a one-quarter lag. That income totaled ¥795.7 billion in the half, or ¥538.7 billion after tax, close to the roughly ¥540 billion the company had estimated from the June-end share price [1][2]. Excluding it, adjusted net income was ¥317.5 billion. ORIX pays out 39% of adjusted earnings, which set the interim dividend at ¥113.56 per share, above the ¥107.27 implied by the earlier forecast [1][2].
The first-half beat rests mainly on one-off items. Adjusted profit includes the ¥124.3 billion pre-tax gain on the ORIX Bank sale, essentially in line with the company's estimate. ORIX did not break out which businesses produced the roughly ¥17.5 billion above forecast [1]. ORIX will not receive cash corresponding to the Kioxia gains [1].
The Kioxia effect turns negative in the third quarter. According to the earnings call summary, management expects a Kioxia loss of about ¥190 billion in the third quarter based on the September-end share price, and aims for adjusted profit of about ¥100 billion per quarter in the second half [3]. The company said it is difficult to reasonably estimate the Kioxia impact on the full year and left its ¥530 billion full-year net income forecast unchanged [1]. The ¥190 billion figure comes only from a machine-generated call summary, does not state whether it is pre-tax or after-tax, and needs to be confirmed in the third-quarter report.
USA & Europe profit halved while recurring income grew
Second-quarter USA & Europe segment profit fell sharply, mainly because private equity gains shrank. Subtracting first-quarter profit of ¥63.0 billion from the first-half total of ¥91.8 billion gives about ¥28.8 billion for the second quarter, less than half the first-quarter level [1][5]. Segment gains on investment securities fell from ¥59.6 billion in the first quarter to about ¥21.5 billion, a decline similar in size to the fall in profit [1][5].
Recurring income from fees and lending kept growing. Second-quarter segment services income, which includes Robeco management fees, was about ¥105.8 billion, above the first quarter and about 35% higher than a year earlier. Installment loans reached ¥835.6 billion at September-end, up from ¥815.7 billion at June-end [1][5]. Management attributed the profit growth to Robeco management fees and to sale and remeasurement gains on private equity investments in the US [3]. The 35% increase includes the consolidation of newly acquired subsidiaries and currency effects.
USA & Europe profit still moves mainly with private equity gains. Excluding securities gains, second-quarter segment profit was about ¥7.3 billion, up from about ¥1.5 billion a year earlier, but still small [1]. Second-quarter profit was still about three times the ¥9.7 billion of a year earlier, while the US portfolio company Hilco still needs to be worked out over the next 24 months [3].
Conclusion
The half-year report confirmed the expected Kioxia gain and ORIX Bank sale, and it showed that most of the first-half profit will not repeat. On growth, first-half new investment of about ¥340 billion was far below the roughly ¥930 billion of cash recovered from investments; reaching the full-year goal of more than ¥800 billion requires about ¥460 billion of new investment in the second half [3]. On profit conversion, adjusted profit includes a one-off sale gain; Insurance segment profit rose about 9% year over year in the second quarter while revenue fell, so growth driven by new policies is not yet proven [1]. On cash, share repurchases in the first half were about ¥146 billion, estimated from the change in treasury stock [1].
The third-quarter report will test whether the Kioxia loss matches the roughly ¥190 billion figure, whether adjusted profit approaches ¥100 billion per quarter, and whether large new investments close.
Sources
[1] IX 6-K filed 2026-11-09 (Q2 FY2027 results), 2026-11-09, Form 6-K [2] IX 6-K filed 2026-08-06 (Q1 FY2027 results) · first-half forecast and Kioxia adjustment, 2026-08-06, Form 6-K, https://www.sec.gov/Archives/edgar/data/1070304/000119312526336507/d128761d6k.htm [3] IX Q2 FY2027 earnings call 2026-11-09 (Drillr call summary), 2026-11-09, earnings call summary [4] IX 20-F filed 2026-06-22 · segment business descriptions, 2026-06-22, Form 20-F, https://www.sec.gov/Archives/edgar/data/1070304/000119312526276640/d29000d20f.htm [5] IX 6-K filed 2026-08-06 (Q1 FY2027 results) · USA & Europe segment, 2026-08-06, Form 6-K, https://www.sec.gov/Archives/edgar/data/1070304/000119312526336507/d128761d6k.htm